Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

BenevolentAI (United Kingdom) | Researchclopedia

Back to institutions

BenevolentAI (United Kingdom)

London, Englandcompany

163

Works

40,465

Citations

67

h-index

Top Research Topics

Computational Drug Discovery Methods Protein Structure and Dynamics Biomedical Text Mining and Ontologies

Top Researchers

Ramachandran S. Vasan Boston University

1,866 works193,189 citationsh-index: 204

Recent Research

Integration of artificial intelligence and high-content screening enabled identification of drugs for long-term treatment of cerebral cavernous malformation disease

Eduardo Frías-Anaya,Helios Gallego-Gutiérrez,et al.

20250 citations

Machine Learning in Materials Science

Bioinformatics and Genomic Networks

COVID-19 Clinical Research Studies

SARS-CoV-2 and COVID-19 Research

Machine Learning in Bioinformatics

Diverse Scientific and Economic Studies

Genetic Associations and Epidemiology

RNA and protein synthesis mechanisms

Theology and Philosophy of Evil

Daniel R. Rhodes

176 works38,099 citationsh-index: 51

John P. Overington Hunter College

186 works29,917 citationsh-index: 54

J. Victor Small

219 works19,518 citationsh-index: 84

Héléna A. Gaspar

97 works15,274 citationsh-index: 43

Michael Carter Bharat Petroleum (India)

643 works12,421 citationsh-index: 60

Discovery of a Potent, Selective, and Brain-Penetrant Checkpoint Kinase 1 Inhibitor, BEN-28010, for the Treatment of Glioblastoma

Michael J. Rawling,Arpita Ray‐Sinha,et al.

20254 citations

Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

Monika A. Myszczynska,Matthew J. Stopford,et al.

20251 citations

Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer

Noah Puleo,Harini Ram,et al.

20253 citations

DOP098 Development of BEN8744, a phase 2 ready, peripherally restricted PDE10 inhibitor targeting a new mechanism of action for the treatment of ulcerative colitis.

J Molnár,Jane McGuffog,et al.

20251 citations

Retrieve to Explain: Evidence-driven Predictions for Explainable Drug Target Identification

Ravi Patel,Angus Brayne,et al.

20251 citations